As the U.S. presidential election looms, the conversation around pharmaceutical policies intensifies, with Vice President Kamala Harris and former President Donald Trump proposing divergent paths. Harris and Trump represent fundamentally different approaches to drug pricing reforms, reflecting
The biotech industry is bustling with innovation and potential, and Xeris Biopharma Holdings Inc (NASDAQ: XERS) is making waves. This article aims to delve deep into the nuts and bolts of Xeris Biopharma’s recent market activities, financial health, insider trading, analysts' ratings, valuation
Lundbeck, the Danish drugmaker, has announced its acquisition of Longboard Pharmaceuticals for $2.6 billion, centering the deal around Longboard's promising experimental brain medicine, bexicaserin. This medicine is in late-stage clinical testing for treating developmental and epileptic
The biopharmaceutical industry is persistently advancing, fueled by innovations and strategic alliances designed to tackle some of the toughest medical challenges. A particularly promising collaboration that has emerged is the partnership between Matica Biotechnology Inc. (Matica Bio) and
The biotechnology industry is currently experiencing a wave of renewed interest, particularly in the field of immunology. A shining example of this trend is Upstream Bio, a Massachusetts-based firm that recently made headlines with its $255 million initial public offering (IPO). The substantial
Oculopharyngeal Muscular Dystrophy (OPMD) is a rare, progressive muscle-wasting disease that significantly impacts patients' quality of life. Limited therapeutic options are available, with current treatments failing to address the underlying muscle weakness driving the disease's progression. This
The biopharmaceutical sector has witnessed a significant surge in investor enthusiasm, and CAMP4 Therapeutics is a testament to this renewed interest. The Cambridge, Massachusetts-based biotech firm has successfully raised $75 million through its initial public offering (IPO), marking it as one of
In recent years, the global Vitamin K2 market has experienced significant growth, driven by rising health awareness and technological advancements. This fat-soluble vitamin, essential for bone and cardiovascular health, has become increasingly popular among consumers and businesses alike. As we
In the rapidly evolving field of biopharmaceutical manufacturing, innovations in mycoplasma and sterility testing are becoming paramount for ensuring product safety and efficacy. Applied Biosystems™ MycoSEQ™ Plus system and the Applied Biosystems™ SteriSEQ™ Rapid Sterility Testing System, both
Eli Lilly is making a bold move to shape the future of pharmaceutical manufacturing with its $4.5 billion investment in the Lilly Medicine Foundry. This new facility, set to open in late 2027 in Lebanon, Indiana's LEAP Research and Innovation District, is poised to redefine how the industry
